Reviva Historical Cash Flow
| RVPH Stock | USD 2.53 0.00 0.00% |
Analysis of Reviva Pharmaceuticals cash flow over time is an excellent tool to project Reviva Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 0.0 or Change To Operating Activities of 2.4 M as it is a great indicator of Reviva Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Reviva |
About Reviva Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Reviva balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Reviva's non-liquid assets can be easily converted into cash.
Reviva Pharmaceuticals Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Depreciation
Depreciation indicates how much of Reviva Pharmaceuticals value has been used up. For tax purposes Reviva Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Reviva Pharmaceuticals Holdings must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Reviva Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Reviva Pharmaceuticals Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Reviva Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. As of now, Reviva Pharmaceuticals' Change To Liabilities is increasing as compared to previous years. The Reviva Pharmaceuticals' current Stock Based Compensation is estimated to increase to about 3.6 M, while Change In Cash is projected to decrease to under 4.1 M.
Reviva Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Reviva Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Reviva Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (118.4K) | 8.8M | 20.9M | (11.2M) | 4.8M | 4.1M | |
| Other Cashflows From Financing Activities | 100K | 12.8M | 98.5K | 19.0K | 5.7M | 3.7M | |
| Total Cash From Operating Activities | (218.4K) | (3.7M) | (10.7M) | (19.0M) | (28.3M) | (26.9M) | |
| Change To Operating Activities | 476.0K | (3.1M) | (203.7K) | 2.0M | 2.3M | 2.4M | |
| Net Income | (846.8K) | (3.8M) | (8.5M) | (24.3M) | (39.3M) | (37.3M) | |
| Total Cash From Financing Activities | 100K | 12.8M | 31.6M | 7.8M | 33.2M | 34.8M | |
| End Period Cash Flow | 193.0 | 8.8M | 29.7M | 18.5M | 23.4M | 14.8M | |
| Change To Netincome | (6.4K) | 2.4M | (1.4M) | 371.4K | 334.3K | 218.1K | |
| Change To Liabilities | 158.2K | 775.1K | (498.5K) | 3.0M | 3.5M | 3.6M |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (2.34) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.